USD23.00
Size:25g Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: a randomized phase III trial Connective Tissue Research FDA panel narrowly backs unapproved peptide drugs – NBC4 Washington https://buhemhealth.com/cdn/shop/files/004-Quality.jpg?v=1765865242&width=3840
USD23.00
USD29.38
USD27.62
USD24.04
USD27.96